These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6223765)

  • 1. Cellular immune function in uremia: altered cytotoxic and suppressor cell responses to an immunomodulating heptapeptide.
    Rola-Pleszczynski M; Bolduc D; Forand S; Plante GE; St-Pierre S
    Clin Immunol Immunopathol; 1983 Aug; 28(2):177-84. PubMed ID: 6223765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cytotoxic cell activity by peptide fragments of beta 2-microglobulin.
    Rola-Pleszczynski M; Bolduc D; Forand S; St Pierre S
    Immunopharmacology; 1985 Feb; 9(1):39-43. PubMed ID: 2985522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulating properties of the uremic pentapeptide H-Asp-Leu-Trp-Glu-Lys-OH in vitro.
    Niese D; Gilsdorf K; Hiester E; Dressen P; Michels S; Dengler HJ
    Klin Wochenschr; 1986 Jul; 64(14):642-7. PubMed ID: 2945038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses and effect of bursin and it analogs on the reduced B lymphocytes of uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1994-1995; 5(3-4):163-70. PubMed ID: 8608325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of suppressor cells in normal lymphocytes by uremic serum.
    Weissgarten J; Modai D; Cohen N; Averbukh Z; Shaked U; Tieder M; Peller S; Kaufman S
    Int Arch Allergy Appl Immunol; 1986; 81(2):180-3. PubMed ID: 2944846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of suppressor cell activity in normal peripheral blood mononuclear cells by sera from predialytic uremic patients.
    Modai D; Berman S; Weissgarten J; Klinovsky E; Cohn M; Averbukh Z
    Int Arch Allergy Appl Immunol; 1990; 92(3):268-71. PubMed ID: 2148928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D-induced suppressor cells in uremic versus normal lymphocytes.
    Modai D; Weissgarten J; Stelian J; Golik A; Averbukh Z; Peller S; Shaked U; Kaufman S; Tieder M
    Int Arch Allergy Appl Immunol; 1988; 86(4):407-11. PubMed ID: 2970438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response in experimentally induced uremia. II. Suppression of PHA response in uremia is mediated by an adherent, Ia-negative and indomethacin-insensitive suppressor cell.
    Alevy YG; Slavin RG
    J Immunol; 1981 May; 126(5):2007-10. PubMed ID: 6163826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral inhibitors of the immune response in uremia. V. Induction of suppressor cells in vitro by uremic serum.
    Raskova J; Raska K
    Am J Pathol; 1983 May; 111(2):149-55. PubMed ID: 6221666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral inhibitors of the immune response in uremia. IV. Effects of serum and of isolated serum very low density lipoprotein from uremic rats on cellular immune reactions in vitro.
    Raskova J; Raska K
    Lab Invest; 1981 Nov; 45(5):410-7. PubMed ID: 6457930
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular immunity and lymphocyte populations in developing uremia in the rat.
    Raskova J; Czerwinski DK; Shea SM; Raska K
    J Exp Pathol; 1986; 2(4):229-45. PubMed ID: 2946817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies in uremic and kidney transplanted patients.
    Langhoff E
    Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of mixed lymphocyte culture by uremic adherent spleen cells and peritoneal macrophages is dependent on a cyclophosphamide-sensitive cell.
    Alevy YG; Mueller KR; Slavin RG
    Int Arch Allergy Appl Immunol; 1984; 74(2):97-103. PubMed ID: 6232223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lymphocyte reactivity by blood transfusions in uremic patients. III. Regulation of cell-mediated lympholysis.
    Klatzmann D; Gluckman JC; Chapuis F; Foucault C
    Transplantation; 1984 Sep; 38(3):222-6. PubMed ID: 6236589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune dysfunction in uremia.
    Cohen G; Haag-Weber M; Hörl WH
    Kidney Int Suppl; 1997 Nov; 62():S79-82. PubMed ID: 9350688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremia as a state of immune deficiency.
    Birkeland SA
    Scand J Immunol; 1976; 5(1-2):107-15. PubMed ID: 131369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of deacetyl-thymosin beta 7 and examination of its immunological effect on the blastogenic response of T-lymphocytes of a uremic patient with cell-mediated immunodeficiency.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):700-7. PubMed ID: 3261642
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodialysis, continuous ambulatory peritoneal dialysis and cellular immunity.
    Collart F; Tielemans C; Dratwa M; Schandene L; Wybran J; Dupont E
    Proc Eur Dial Transplant Assoc; 1983; 20():190-4. PubMed ID: 6228939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytes from multitransfused uremic patients have poor MLC reactivity.
    Fehrman I; Ringdén O
    Tissue Antigens; 1981; 17(4):386-95. PubMed ID: 6460343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional roles of phenylalanine(7) of thymic humoral factor-gamma 2 in the impaired blastogenic response of uremic T-lymphocytes.
    Abiko T; Sekino H
    Drug Dev Ind Pharm; 1998 Jun; 24(6):569-72. PubMed ID: 9876625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.